China
Africa
Explore chapters and articles related to this topic
Telemedicine Abortion
Published in Nicholas Colgrove, Bruce P. Blackshaw, Daniel Rodger, Agency, Pregnancy and Persons, 2023
The only study cited with significant quantitative data on the safety of full telemedicine was Aiken et al. (2021). Their claim that telemedicine in England led to abortions at earlier gestations has been dispensed with above. The authors claim that only 1.2% of women had unsuccessful abortions in the telemedicine program, with only 0.7% requiring evacuation of retained products of conception. They claim that their sample constituted 85% of all medical abortions provided nationally from April to June 2020.
Dejar pasar
Published in Hanna Laako, Georgina Sánchez-Ramírez, Midwives in Mexico, 2021
Georgina Sánchez-Ramírez, Geicel Llamileth Benítez Fuentes
According to the WHO (2015), the advantage of medical abortions is that they can be administered not only by medical personnel and in hospital settings, but also by properly trained health personnel such as nurses, health promoters and professional midwives. However, traditional midwives are not mentioned in the WHO’s report. Nevertheless, they will be discussed in this chapter, which argues that these midwives do indeed carry out safe and reliable abortions in line with the WHO’s regulations.
Pregnancy – wanted and unwanted
Published in Suzanne Everett, Handbook of Contraception and Sexual Health, 2020
The main methods of abortion are: Surgical abortion, which can be carried out by: Vacuum aspiration.Dilatation and curettage (D&C).Dilatation and evacuation (D&E).Medical abortion.
Policy surveillance for a global analysis of national abortion laws
Published in Sexual and Reproductive Health Matters, 2022
Patty Skuster, Jamie Menzel, Adrienne R. Ghorashi, Megan Perkins
Governments around the world have liberalised abortion laws to improve access and uphold human rights. However, even recently liberalised abortion laws continue to impose medically unnecessary requirements for abortion which are not based on evidence.6 Evidence is growing that people can safely end their pregnancies with misoprostol alone or with mifepristone, without the involvement of a healthcare worker and outside a healthcare facility.1–5 As access to and awareness of abortion with medicine has grown, abortion outside formal healthcare settings has become safer. Previously, pregnant people ended pregnancies outside formal healthcare settings through invasive methods such as sticks, chemicals, or physical force.10 But with non-invasive medicines, the risk to health and life associated with clandestine abortion is reduced. In its new Abortion Care Guideline, the World Health Organization recommends, for abortions at fewer than 12 weeks, the option of self-management of the medical abortion process, in whole or in part.11 Researchers have attributed self-managed abortion with pills to a worldwide decrease in abortion mortality.12
In-person later abortion accompaniment: a feminist collective-facilitated self-care practice in Latin America
Published in Sexual and Reproductive Health Matters, 2022
Chiara Bercu, Heidi Moseson, Julia McReynolds-Pérez, Emily Wilkinson Salamea, Belén Grosso, María Trpin, Ruth Zurbriggen, Carolina Cisternas, Milena Meza, Viviana Díaz, Katrina Kimport
In recent decades, medical abortion without clinical supervision has emerged as an important self-care practice for people to access safe abortion and exercise their reproductive autonomy.7 A self-managed medical abortion involves taking misoprostol, alone or in combination with mifepristone, to end a pregnancy without clinical supervision.9 Self-managed medical abortions are common across legal contexts, and a robust body of evidence has demonstrated that self-managed medical abortions are safe and effective self-care interventions when the person has access to accurate information on how to take the pills.10 Medical abortion, both with and without clinical supervision, is highly effective in the first trimester of pregnancy.11,12 Additionally, the World Health Organization (WHO)’s “Medical Management of Abortion” guidelines provide guidance of use of these medications at later durations of pregnancy, beyond 12 weeks, and with no upper limit.11 Furthermore, research suggests that people can safely and effectively self-manage medical abortions beyond 12 weeks gestation.13–15
Medical abortion through telehealth in India: a critical perspective
Published in Sexual and Reproductive Health Matters, 2022
Dipika Jain, Anubha Rastogi, Kavya Kartik, Anmol Diwan, Oieshi Saha
Medical abortions are allowed to be performed through a combination of mifepristone and misoprostol pills, or through prescription (by RMPs) of higher dosages of misoprostol alone when mifepristone is unavailable or unaffordable.17 In India, amendments to the rules and regulations governing the MTP Act in 2002 allowed for medical abortions, approving the combined mifepristone-misoprostol regimen for early termination of pregnancies (up to 7 weeks). The Rules were amended again in 2003 to specify that medical abortions could be provided by certified providers in their clinics, on the condition that there was access to a registered and approved facility for back-up and that the clinic displayed a certificate of approval from the site’s owner. The latest amendment to the MTP Rules in 2021 has retained all previous provisions while extending the gestational age to 9 weeks to obtain a medically managed abortion.